Voyager Therapeutics (VYGR) EBITDA Margin Growth (1y) (2016 - 2026)
Voyager Therapeutics (VYGR) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -63,141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63,141.00 |
| Dec 31, 2025 | 41,313.00 |
| Sep 30, 2025 | -17,296.00 |
| Jun 30, 2025 | -65,353.00 |
| Mar 31, 2025 | -45,298.00 |
| Dec 31, 2024 | -66,782.00 |
| Sep 30, 2024 | 58,356.00 |
| Jun 30, 2024 | 46,810.00 |
| Mar 31, 2024 | -16,465.00 |
| Dec 31, 2023 | -152,471.00 |
| Sep 30, 2023 | -67,466.00 |
| Jun 30, 2023 | 220,119.00 |
| Mar 31, 2023 | 332,634.00 |
| Dec 31, 2022 | 156,440.00 |
| Sep 30, 2022 | 173,191.00 |
| Jun 30, 2022 | -61,360.00 |
| Mar 31, 2022 | -285,106.00 |
| Dec 31, 2021 | 38,331.00 |
| Sep 30, 2021 | -176,849.00 |
| Jun 30, 2021 | -207,517.00 |